Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALPN-101 in Adult Healthy Volunteers

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALPN-101 in Adult Healthy Volunteers

Status: Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 06 Nov 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs ALPN 101 (Primary) ; ALPN 101 (Primary)
  • Indications Autoimmune disorders; Graft-versus-host disease; Haemophagocytic lymphohistiocytosis; Inflammation; Psoriatic arthritis
  • Focus Adverse reactions; First in man
  • Acronyms BALANCE
  • Sponsors Alpine Immune Sciences
  • Most Recent Events

    • 06 Nov 2019 According to an Alpine Immune Sciences media release, data from this will be presented at the 61st American Society of Hematology (ASH) Annual Meeting and Exposition to be held December 7-10, 2019 in Orlando, FL.
    • 30 Oct 2019 According to an Alpine Immune Sciences media release, enrolment in all planned cohorts are completed in this study. The preliminary findings from this study will be discuss in the third quarter 2019 company update conference call.
    • 08 Oct 2019 Planned End Date changed from 1 Nov 2019 to 1 Dec 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top